- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Immediate Type Hypersensitivity in Canada
Total 5041 results
-
GlaxoSmithKlineCompletedAsthmaUnited States, Australia, Germany, Russian Federation, Bulgaria, Canada, Chile, Peru, Philippines, South Africa, Thailand, Mexico, Israel, Ukraine, New Zealand, Croatia
-
Novartis PharmaceuticalsTerminatedAsthmaGermany, United States, Korea, Republic of, Poland, United Kingdom, Israel, Russian Federation, Italy, Turkey, Argentina, France, Hungary, Mexico, Canada, Czechia, Finland, Portugal, Romania, Slovakia, South Africa
-
GlaxoSmithKlineCompletedAsthmaCanada, Bulgaria, Estonia, Spain, Netherlands, Germany, Australia, Austria, Belgium, Finland, Ireland, Latvia, Macedonia, The Former Yugoslav Republic of, New Zealand, United Kingdom
-
Kymera Therapeutics, Inc.York Dermatology Clinic and Research CentreCompletedDermatitis, Atopic | Hidradenitis SuppurativaCanada
-
Teva Branded Pharmaceutical Products R&D, Inc.PPDCompletedAsthmaUnited States, Argentina, Australia, Belgium, Canada, Czechia, France, Germany, Hungary, Israel, Japan, Korea, Republic of, Mexico, New Zealand, Poland, Romania, Russian Federation, South Africa, Spain, Turkey, Ukraine
-
Novartis PharmaceuticalsCompletedAsthmaUnited States, India, Spain, Italy, Israel, Netherlands, Russian Federation, Lebanon, South Africa, Czechia, Greece, Serbia, Argentina, Mexico, Slovakia, Canada, Taiwan, Malaysia, Japan
-
SanofiCompletedAsthmaSpain, Korea, Republic of, Chile, Mexico, United Kingdom, Argentina, Bulgaria, Canada, Hungary, Poland, Romania, Turkey, Germany
-
GlaxoSmithKlineCompletedAsthmaUnited States, Argentina, Australia, France, Germany, Poland, Romania, Russian Federation, Canada, Chile, Korea, Republic of, Ukraine, United Kingdom
-
PfizerCompletedAsthmaUnited States, Canada
-
AstraZenecaRecruitingAsthmaUnited States, Canada, South Africa, Korea, Republic of, Philippines, Czechia, Malaysia, Germany
-
Regeneron PharmaceuticalsSanofiActive, not recruitingAsthmaUnited States, United Kingdom, Canada, France, Puerto Rico, Japan, Spain, Denmark, Italy, Sweden
-
GlaxoSmithKlineIqvia Pty LtdActive, not recruitingAsthmaUnited States, Japan, Poland, Spain, Italy, Australia, Taiwan, France, Hungary, Canada, Czechia
-
SanofiRegeneron PharmaceuticalsRecruiting
-
Novartis PharmaceuticalsTerminatedAsthmaGermany, United States, Belgium, Poland, Latvia, Argentina, Guatemala, Philippines, Slovakia, Czechia, Hungary, Russian Federation, Japan, Bulgaria, Canada
-
MedImmune LLCCompletedAsthmaUnited States, Czech Republic, France, Korea, Republic of, Mexico, Poland, Russian Federation, Spain, United Kingdom, Germany, Philippines, Argentina, Canada, Chile, Japan
-
AstraZenecaCompletedAsthmaHungary, South Africa, Poland, Spain, Canada, Australia, Czech Republic
-
GlaxoSmithKlineCompletedAsthmaUnited States, Canada, France, Germany, United Kingdom, Australia
-
SanofiRegeneron PharmaceuticalsActive, not recruitingAsthmaMexico, Spain, Argentina, Japan, Poland, United States, Turkey, Australia, Brazil, Canada, Chile, Colombia, Hungary, Italy, Lithuania, Russian Federation, South Africa, Ukraine
-
GlaxoSmithKlineCompletedAsthmaUnited States, Argentina, Philippines, Canada, Brazil
-
SunovionCompletedAsthmaUnited States, Canada
-
Kindeva Drug DeliveryCompleted
-
Boehringer IngelheimTerminatedDermatitis, AtopicUnited States, Japan, Canada
-
GlaxoSmithKlineCompletedAsthmaUnited States, Argentina, Australia, Canada, France, Germany, Japan, Russian Federation, Spain, Ukraine, Belgium, Chile, Korea, Republic of, Mexico, Italy, United Kingdom
-
AstraZenecaAmgenCompletedAsthmaUnited States, Austria, Canada, France, Germany, Taiwan, Vietnam, Korea, Republic of, Brazil, Japan, Argentina, Australia, Israel, Russian Federation, Saudi Arabia, South Africa, Ukraine, United Kingdom
-
AstraZenecaAmgenRecruitingAsthmaUnited States, Canada, Czechia, Korea, Republic of, India, Mexico, Turkey, Chile, Brazil, Thailand, Colombia, Poland, Peru, Malaysia, Philippines
-
AmgenAstraZeneca; Kyowa Kirin Co., Ltd.TerminatedAsthmaUnited States, Canada, France, Germany, Italy, Taiwan, Hong Kong, Australia, Greece, Russian Federation, Poland, Ireland, Puerto Rico, Korea, Republic of, New Zealand
-
Hoffmann-La RocheCompletedAsthmaUnited States, Canada, United Kingdom, Sweden, France, Ireland
-
PurGenesis Technologies Inc.CompletedAtopic Dermatitis EczemaCanada
-
Novartis PharmaceuticalsCompletedChronic UrticariaColombia, Dominican Republic, Guatemala, Peru, Brazil, Argentina, Honduras, Panama, Costa Rica
-
SkyePharma AGCompleted
-
Dermavant Sciences GmbHCompletedAtopic DermatitisUnited States, Canada
-
Novartis PharmaceuticalsCompletedAsthmaGermany, United States, India, Korea, Republic of, Italy, Russian Federation, Sweden, Israel, Spain, Peru, Brazil, Bulgaria, Hungary, Vietnam, Canada, Colombia, Puerto Rico, Tunisia
-
Hoffmann-La RocheCompletedAsthmaUnited States, South Africa, Russian Federation, Puerto Rico, New Zealand, Poland, Bulgaria, Romania, Brazil, Canada, United Kingdom, Czech Republic, Georgia, Slovakia
-
Teva Branded Pharmaceutical Products R&D, Inc.TerminatedAsthmaUnited States, Bulgaria, Czechia, Germany, Poland
-
SanofiActive, not recruitingDose Ranging Study of Amlitelimab in Adult Participants With Moderate-to-severe Asthma (TIDE-asthma)AsthmaUnited States, Argentina, Brazil, Canada, Chile, Hungary, Italy, Japan, Korea, Republic of, Mexico, Poland, South Africa, Turkey, United Kingdom
-
Regeneron PharmaceuticalsSanofiCompletedAllergic RhinitisUnited States, Canada
-
AstraZenecaCompleted
-
Novartis PharmaceuticalsCompletedAsthmaGermany, United States, India, Korea, Republic of, Poland, Romania, South Africa, France, Hungary, United Kingdom, Israel, Russian Federation, Turkey, Italy, Argentina, Mexico, Canada, Czechia, Finland, Portugal, Slovakia, Singapore, Guatema... and more
-
AstraZenecaAmgenCompletedRespiratory Tract Diseases | Immune System Diseases | Lung Diseases | Hypersensitivity | Hypersensitivity, Immediate | Bronchial Diseases | Lung Diseases, Obstructive | Asthma | Respiratory HypersensitivityUnited States, Canada, Denmark, United Kingdom, Germany
-
GlaxoSmithKlineCompletedDermatitis, AtopicUnited States, Canada
-
Boehringer IngelheimCompleted
-
Vitae Pharmaceuticals, Inc.CompletedDermatitis, AtopicUnited States, Canada
-
Novartis PharmaceuticalsCompletedAsthmaGermany, Slovakia, Poland, Belgium, Estonia, Hungary, Latvia, Lithuania, Turkey, Canada, India, Netherlands, Ukraine, Russian Federation, Malaysia, Japan, Thailand
-
Hoffmann-La RocheCompletedAsthmaUnited States
-
Boehringer IngelheimPfizerCompletedAsthmaUnited States, Bulgaria, Canada, Germany, Guatemala, Hungary, Korea, Republic of, Latvia, Lithuania, Norway, Portugal, Romania, Russian Federation, Sweden, Ukraine, United Kingdom
-
Rigel PharmaceuticalsCompletedAsthmaUnited States, Canada
-
GlaxoSmithKlineCompletedAsthmaUnited States, Russian Federation, Canada, Germany, Peru, Australia, Mexico, Chile, Costa Rica, Spain, Poland, Lithuania, Latvia
-
Novartis PharmaceuticalsCompletedChronic Spontaneous UrticariaArgentina, Dominican Republic, Canada, Brazil, Guatemala, Chile, Mexico, Panama
-
GlaxoSmithKlineCompletedAsthmaUnited States, Argentina, Australia, Canada, France, Germany, Japan, Netherlands, Poland, Russian Federation, Spain, Ukraine, Belgium, Chile, Korea, Republic of, United Kingdom, Czechia, Mexico, Italy
-
Novartis PharmaceuticalsCompletedAsthmaUnited States, Colombia, India, Romania, South Africa, Italy, Hungary, France, Bulgaria, Turkey, Greece, Guatemala, Japan, Argentina, Austria, Mexico, Netherlands, Peru, Poland, Russian Federation, United Kingdom, Canada